By: Adam Feuerstein | 01/21/14 - 07:00 AM ESTThe chart solidifies you what you already know: Biotech stocks are off to a blistering start in 2014.
The iShares Nasdaq Biotechnology Index ETF (IBB) is trouncing the S&P 500 through the first three weeks of the year.
Here's the same IBB vs. S&P 500 comparison as above, but looking at the first 20 calendar days of 2013:
07/29/14 - 10:26 AM EDT
07/28/14 - 12:34 PM EDT
07/28/14 - 10:56 AM EDT
07/28/14 - 09:44 AM EDT
07/25/14 - 11:30 AM EDT
David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Access the tool that DOMINATES the Russell 2000 and the S&P 500.